Dr. Black on Selecting Immunotherapy Agents in Bladder Cancer – OncLive
OncLive |
Dr. Black on Selecting Immunotherapy Agents in Bladder Cancer
OncLive Peter Black, MD, senior research scientist, Vancouver Prostate Centre, associate professor, Department of Urologic Sciences, University of British Columbia, discusses selecting immunotherapy agents in bladder cancer. Right now, there is not a clear-cut … |
